Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828397 | PMC |
| http://dx.doi.org/10.5021/ad.2016.28.2.257 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Resolution of Erythema Annulare Centrifugum With Lung Cancer Drug Therapy: A Case Report.
Cureus
November 2024
Department of Dermatology, Japanese Red Cross Akita Hospital, Akita, JPN.
Tumor-associated erythema annulare centrifugum is commonly observed in leukemia and lymphoma. In this case, we reported erythema annulare centrifugum associated with lung cancer that resolved following targeted drug therapy. A 71-year-old man with psoriasis visited our hospital with erythema annulare and pruritus.
View Article and Find Full Text PDFClinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors.
Arch Dermatol Res
October 2024
College of Pharmacy, Changsha Medical University, No. 1501 Leifeng Avenue, Xiangjiang New District, Changsha, Hunan, 410219, China.
PD-1/PD-L1 inhibitors have increasingly been associated with the occurrence of subacute cutaneous lupus erythematosus (SCLE), but the clinical characteristics and outcomes remain under-explored. Literature on PD-1/PD-L1 inhibitors induced SCLE was retrieved from Chinese and English databases until June 31, 2024, and clinical data of patients were extracted for retrospective analysis. Twenty-nine patients participated, with a median age of 63 years (range 43, 80).
View Article and Find Full Text PDFErythroderma Following Pfizer-BioNTech COVID-19 Vaccination in a Patient With Atopic Dermatitis: A Case Report.
Cureus
September 2024
Dermatology, Imperial Dermatology, Hollywood, USA.
Article Synopsis
- Cutaneous reactions to mRNA COVID-19 vaccines can include various skin issues, especially in patients with existing dermatologic diseases.
- A case report details a 73-year-old man with atopic dermatitis who developed severe erythroderma after each Pfizer-BioNTech vaccine dose, which covered 95% of his body.
- Quick identification and treatment of erythroderma are crucial to prevent serious complications, highlighting the need for awareness of this reaction in susceptible individuals.
Erythema nodosum as first clinical sign of acute Borrelia burgdorferi infection.
Braz J Infect Dis
December 2024
Onkoderma- Clinic for Dermatology, Venereology and Dermatologic Surgery, Bulgaria; Department of Dermatology and Venereology, Medical Institute of Ministry of Interior, Bulgaria.
Article Synopsis
- Lyme borreliosis, commonly known as Lyme disease, is a worldwide tick-borne infection caused by the Borrelia burgdorferi species, often starting with a distinctive erythema migrans rash at the bite site.
- Other skin symptoms may also appear initially, leading to potential misdiagnosis and treatment delays, highlighting the need for comprehensive evaluation of clinical findings, serology, and histology.
- A case of a 78-year-old woman revealed erythema nodosum as her initial manifestation following a tick bite; she was effectively treated with antibiotics and anti-inflammatory medications, and prescribed adjustments for her outpatient care.
Treatment Outcomes in Erythema Annulare Centrifugum: A Systematic Review.
J Cutan Med Surg
September 2024
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!